Oliver Qiangzhe Zhang, Ph.D.

Oliver Qiangzhe Zhang, Ph.D. is currently working as an Associate Scientist at Entos Pharmaceuticals, leading lipid nanoparticle formulation screening studies. Prior to this, Oliver worked as a Scientist at INOVIO Pharmaceuticals, Inc., where Oliver Qiangzhe designed and evaluated DNA-encoded therapeutic antibodies for cancer immunotherapy. Oliver Qiangzhe also has experience as a Postdoctoral Researcher at the University of California San Diego, focusing on upstream process development for cellular materials production and formulation development of cellular nanosponges. Throughout their academic journey, Oliver has been involved in various research projects related to nanosponge technology and bioengineering.